https://www.selleckchem.com/pr....oducts/elafibranor.h
13 and 1.56 µg/mL, respectively, which were nontoxic for human THP-1 and A549 cells. #link# The NorA inhibition was confirmed by SA-1199B ethidium bromide efflux and checkerboard assays against the isogenic pair SA-K2378 (norA++)/SA-K1902 (norA-). These in vitro results indicate the two compounds as valuable structures for designing novel S. aureus NorA inhibitors to be used in association with fluoroquinolones.Background and objectives Hyperuricemia is one of the well-known cardiovascular risk factors. There is a growing interest i
Like
Comment
Share
